TY - JOUR
T1 - A mixed-methods study to define Textbook Outcome for the treatment of patients with uncomplicated symptomatic gallstone disease with hospital variation analyses in Dutch trial data
AU - Thunnissen, Floris M.
AU - Comes, Daan J.
AU - Latenstein, Carmen S. S.
AU - Stommel, Martijn W. J.
AU - van Laarhoven, Cornelis J. H. M.
AU - Drenth, Joost P. H.
AU - Lantinga, Marten A.
AU - Atsma, Femke
AU - de Reuver, Philip R.
AU - Eijsbouts, Quirijn A. J.
AU - Heisterkamp, Joos
AU - Boerma, Djamila
AU - Jennifer, M. J.
AU - van Duivendijk, Peter
AU - Wiering, Bastiaan
AU - Boermeester, Marja A.
AU - Diepenhorst, Gwen
AU - van der Bilt, Jarmila
AU - Buyne, Otmar
AU - Venneman, Niels G.
AU - Keszthelyi, Daniel
AU - Ahmed, Ifran
AU - Hugh, Thomas J.
AU - Wigmore, Stephen J.
AU - Strasberg, Steven M.
AU - Harrison, Ewen M.
AU - Lammert, Frank
AU - Gurusamy, Kurinchi
AU - Moris, Dimitros
AU - Soreide, Kjetil
AU - Pappas, Theodore N.
AU - Kapoor, Vinay K.
AU - Invited International Collaborators
AU - Speelman, Antonia
AU - van den Brink, Chris
N1 - Publisher Copyright: © 2023 The Author(s)
PY - 2023/9
Y1 - 2023/9
N2 - Background: International consensus on the ideal outcome for treatment of uncomplicated symptomatic gallstone disease is absent. This mixed-method study defined a Textbook Outcome (TO) for this large group of patients. Methods: First, expert meetings were organised with stakeholders to design the survey and identify possible outcomes. To reach consensus, results from expert meetings were converted in a survey for clinicians and for patients. During the final expert meeting, clinicians and patients discussed survey outcomes and a definitive TO was formulated. Subsequently, TO-rate and hospital variation were analysed in Dutch hospital data from patients with uncomplicated gallstone disease. Results: First expert meetings returned 32 outcomes. Outcomes were distributed in a survey among 830 clinicians from 81 countries and 645 Dutch patients. Consensus-based TO was defined as no more biliary colic, no biliary and surgical complications, and the absence or reduction of abdominal pain. Analysis of individual patient data showed that TO was achieved in 64.2% (1002/1561). Adjusted-TO rates showed modest variation between hospitals (56.6-74.9%). Conclusion: TO for treatment of uncomplicated gallstone disease was defined as no more biliary colic, no biliary and surgical complications, and absence or reduction of abdominal pain.TO may optimise consistent outcome reporting in care and guidelines for treating uncomplicated gallstone disease.
AB - Background: International consensus on the ideal outcome for treatment of uncomplicated symptomatic gallstone disease is absent. This mixed-method study defined a Textbook Outcome (TO) for this large group of patients. Methods: First, expert meetings were organised with stakeholders to design the survey and identify possible outcomes. To reach consensus, results from expert meetings were converted in a survey for clinicians and for patients. During the final expert meeting, clinicians and patients discussed survey outcomes and a definitive TO was formulated. Subsequently, TO-rate and hospital variation were analysed in Dutch hospital data from patients with uncomplicated gallstone disease. Results: First expert meetings returned 32 outcomes. Outcomes were distributed in a survey among 830 clinicians from 81 countries and 645 Dutch patients. Consensus-based TO was defined as no more biliary colic, no biliary and surgical complications, and the absence or reduction of abdominal pain. Analysis of individual patient data showed that TO was achieved in 64.2% (1002/1561). Adjusted-TO rates showed modest variation between hospitals (56.6-74.9%). Conclusion: TO for treatment of uncomplicated gallstone disease was defined as no more biliary colic, no biliary and surgical complications, and absence or reduction of abdominal pain.TO may optimise consistent outcome reporting in care and guidelines for treating uncomplicated gallstone disease.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85163386609&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/37301634
UR - http://www.scopus.com/inward/record.url?scp=85163386609&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.hpb.2023.05.005
DO - https://doi.org/10.1016/j.hpb.2023.05.005
M3 - Article
C2 - 37301634
SN - 1365-182X
VL - 25
SP - 1000
EP - 1010
JO - HPB
JF - HPB
IS - 9
ER -